Common Contracts
2 similar Restricted Stock Unit Award Agreement contracts by Pardes Biosciences, Inc.
RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE PARDES BIOSCIENCES, INC.Restricted Stock Unit Award Agreement • March 2nd, 2022 • Pardes Biosciences, Inc. • Pharmaceutical preparations
Pursuant to the Pardes Biosciences, Inc. 2022 Inducement Plan (the “Plan”), Pardes Biosciences, Inc. (the “Company”) hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one share of Common Stock, par value $0.0001 per share (the “Stock”), of the Company. This Award has been granted as an inducement pursuant to Rule 5635(c)(4) of the Marketplace Rules of NASDAQ Stock Market, Inc.
ASSUMED INCENTIVE STOCK OPTION AGREEMENT UNDER THE PARDES BIOSCIENCES, INC.Restricted Stock Unit Award Agreement • December 30th, 2021 • Pardes Biosciences, Inc. • Pharmaceutical preparations
Reference is made to that certain Agreement and Plan of Merger dated June 29, 2021, as amended as of November 7, 2021 (the “Merger Agreement”), by and among the Pardes Biosciences, Inc., f/k/a FS Development Corp. II, (the “Company”), Pardes Biosciences, Inc., Orchard Merger Sub, Inc. and Shareholder Representative Services LLC, as Stockholders’ Representative. This incentive stock option agreement evidences the incentive stock option award granted to Optionee (the “Assumed Option”) under the Pardes Biosciences, Inc. 2020 Stock Plan (the “2020 Plan”). Pursuant to Section 3.1(b) of the Merger Agreement, the Assumed Option was assumed by the Company as of the Effective Time (as defined in the Merger Agreement) and continues in full force and effect under the Pardes Biosciences, Inc. 2021 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”). Subject to difference between the Plan and the 2020 Plan, which are not deemed material or adverse to Optionee, the Assume
